Recapitulating X-Linked Juvenile Retinoschisis in Mouse Model by Knock-In Patient-Specific Novel Mutation

Ding Chen1,2, Tao Xu1,2, Mengjun Tu1,2

  • 1State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.

Insights

Researchers created a new mouse model for X-linked juvenile retinoschisis (XLRS) with a patient-specific mutation. This RS1-KI mouse model shows retinal degeneration and will aid in developing gene therapies for XLRS.

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • X-linked juvenile retinoschisis (XLRS) is a genetic retinal disorder caused by mutations in the RS1 gene.
  • XLRS leads to significant visual impairment and blindness, necessitating effective therapeutic strategies.
  • Developing patient-specific animal models is crucial for advancing gene therapy research.

Purpose of the Study:

  • To generate a knock-in mouse model harboring the specific p.Y65X mutation identified in a patient family with XLRS.
  • To characterize the retinal phenotype and electroretinographic (ERG) abnormalities in the generated RS1-KI mice.
  • To establish a valuable preclinical tool for developing genome editing-based gene therapies for XLRS.

Main Methods:

  • Recruitment of an XLRS patient family and identification of the causative RS1 mutation (p.Y65X).
  • Generation of a knock-in mouse model (RS1-KI) using TALEN technology to introduce the patient-specific mutation.
  • Assessment of retinal structure and function using electroretinography (ERG) and histological analysis.

Main Results:

  • The RS1-KI mice exhibited significantly decreased b-wave amplitudes in ERG recordings, indicating impaired retinal function.
  • Histological examination revealed retinal structural abnormalities in RS1-KI mice, including disorganization of nuclear layers and photoreceptor degeneration.
  • The generated knock-in model accurately recapitulates key pathological features of human XLRS.

Conclusions:

  • The novel RS1-KI mouse model carrying the patient-specific p.Y65X mutation is successfully generated.
  • This model demonstrates functional and structural retinal deficits consistent with XLRS.
  • The RS1-KI mice serve as a valuable preclinical platform for evaluating genome editing strategies for XLRS treatment.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.7K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
16
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.7K